Rimot ramps up rapid COVID-19 screening tool

Dartmouth company develops remote monitoring service for virus management

Rimot received a boost from the federal government to help get its screening tool for indicators of COVID-19 to market.

A loan of $904,267 to support the commercialization of RIMOTHEALTH from the Dartmouth company was announced Thursday. The funding is through the Atlantic Canada Opportunities

Agency's Regional Economic Growth Through Innovation program.

Rimot's COVID-19 virus detection device is said to be safer, faster and more costeffective than manual screening.

The money will help Rimot grow, enter new markets and hire skilled workers in data science, system design and market development, according to a news release.

“Our RIMOTHEALTH solution is being purchased and deployed by organizations across Canada, the United States and now the United Kingdom,” Andrew Boswell, CEO of Rimot, said in the release.

“Our work is all about helping companies and public-sector organizations have safer facilities for COVID-19 and beyond, setting a new standard for health and safety into the future. This support from the Government of Canada will accelerate Rimot's commercialization and reach into current and new markets.”

RIMOTHEALTH is described as monitoring health questionaire responses and body temperatures to ensure workplaces can operate safely and productively.

The money announced Thursday will also support the development of RIMOTSHIP, which is said to provide operational insights for commercial and military ships.

RIMOTHEALTH and RIMOTSHIP join Rimotrf, the company's initial remote monitoring service, to help businesses reduce costs and increase productivity. Rimotrf is described as the first turn-key service to remotely monitor transmitter sites and equipment.

Founded in 2016, Rimot is a startup technology company that employs 14.